1. A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Caimi, P.F.; Eder, J.P.; Jacobsen, E.D.; Jacobson, C.A.; LaCasce, A.S.; Shipp, M.A.; Chapuy, B.; Labriola‐Tomphins, E.; Boisserie, F.; Passe, S.; Chesné, E.; Pierceall, W.; Zhi, J.; DeMario, M.; Vaishampayan, U.; Dowlati, A.; Shapiro, G.I.; Fisher, D.C.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953). (October 2020) Authors: Do, K.T.; Frej, K.; Bhushan, K.; Pruitt-Thompson, S.; Zheleva, D.; Blake, D.; Chiao, J.; Shapiro, G.I. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Shipping noise in a dynamic sea: a case study of grey seals in the Celtic Sea. Issue 1 (15th January 2017) Authors: Chen, F.; Shapiro, G.I.; Bennett, K.A.; Ingram, S.N.; Thompson, D.; Vincent, C.; Russell, D.J.F.; Embling, C.B. Journal: Marine pollution bulletin Issue: Volume 114:Issue 1(2017:Jan.) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗